Baricitinib plus dexamethasone compared to dexamethasone for the treatment of severe COVID-19 pneumonia: A retrospective analysis

Objective: We aimed to analyze clinical outcomes from patients with severe COVID-19 pneumonia that received either baricitinib plus dexamethasone or dexamethasone monotherapy. Methodology: We performed a retrospective comparative study. Data from hospitalized patients with severe COVID-19 pneumon...

Full description

Bibliographic Details

Main Authors:	Pérez Alba, Eduardo, Nuzzolo Shihadeh, Laura Marina, Aguirre García, Gloria Mayela, Espinosa Mora, Jaime Eugenio, Lecona García, Juan Diego, Flores Pérez, Rómulo Omar, Mendoza Garza, Marisela, Camacho Ortiz, Adrián
Format:	Article
Language:	Spanish / Castilian
Published:	Scientific Communications International 2021
Subjects:	QR Microbiología
Online Access:	http://eprints.uanl.mx/22454/1/22454.pdf